12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

  • AcelRx Pharmaceuticals ACRX stock increased by 38.9% to $0.36 during Wednesday's after-market session. AcelRx Pharmaceuticals's trading volume hit 4.7 million shares by close, accounting for 336.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $52.9 million.
  • Clearside Biomedical CLSD stock rose 14.17% to $1.61. The market value of their outstanding shares is at $96.8 million.
  • Quotient QTNT stock increased by 8.43% to $0.27. Today's trading volume for this security ended up closing at 3.7 million shares, which is 242.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $36.6 million.
  • Agile Therapeutics AGRX stock rose 8.42% to $0.74. Trading volume for this security closed at 3.2 million, accounting for 21.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.3 million.
  • Qualigen Therapeutics QLGN shares increased by 7.89% to $0.54. The company's market cap stands at $20.9 million.
  • Stealth BioTherapeutics MITO stock rose 7.88% to $0.24. The market value of their outstanding shares is at $17.5 million.

Losers

  • CytomX Therapeutics CTMX shares decreased by 28.9% to $1.4 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 811.9K shares, which is 74.4 percent of its average volume over the last 100 days. The company's market cap stands at $91.5 million.
  • Vor Biopharma VOR shares declined by 10.99% to $4.54. The market value of their outstanding shares is at $170.6 million.
  • Titan Pharmaceuticals TTNP stock decreased by 8.91% to $0.82. Today's trading volume for this security ended up closing at 437.3K shares, which is 92.4 percent of its average volume over the last 100 days. The company's market cap stands at $11.9 million.
  • SomaLogic SLGC stock fell 6.91% to $4.45. The company's market cap stands at $811.1 million.
  • Adagio Therapeutics ADGI stock decreased by 6.09% to $3.55. The market value of their outstanding shares is at $389.5 million.
  • Adverum Biotechnologies ADVM stock declined by 5.7% to $1.16. The company's market cap stands at $114.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-TFMMovers

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.